By the end of this webinar, you will be able to:
- Understand the evidence-based guidance and dose recommendations when treating or preventing Alcohol withdrawal syndrome (AWS), in light of recent drug discontinuations/shortages.
- See how Psychotropic Drug Directory has evolved over nearly 2 years since it was launched on MedicinesComplete and be aware of some exciting new guidance on weight gain and GLP-1 agonists.
- With a real-life case study see how Psychotropic Drug Directory can support day to day queries.
Why this matters:
Management of drug shortages and discontinuations is a common challenge, especially in mental health care. Trusted, evidence-based guidance is crucial when safely managing patients through the change.






Matt Orzlowski
Nicola Greenhalgh



